NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th

2025-02-07 New York Stock ExchangeHaiPress

NEW YORK,Feb. 5,2025 -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.

Feb_5_2025_Market_Update

Kristen Scholer delivers the pre-market update on February 5th

Amid disappointing earnings results,stocks lower in extended trade

China announces 15% levy on U.S. goods

Alphabet earnings miss estimates in latest quarter

Watch NYSE TV Live every weekday 9:00-10:00am ET

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

IRCODE INTRODUCES LIVE+: A NEW STANDARD FOR REAL-TIME INTERACTION AND LIVE COMMERCE

02-07

Clarifai Partners with Arrow Electronics to Accelerate Commercial AI Adoption and Distribution

02-07

Supermicro Ramps Full Production of NVIDIA Blackwell Rack-Scale Solutions with NVIDIA HGX B200

02-07

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

02-07

Datasea Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year

02-07

Samsung Electro-Mechanics Unveils World's First MLCC for LiDAR Applications

02-07

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

02-07

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 5th

02-07

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances

02-07

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

02-07